Product Highlight - Basalog
A quality alternative of basal insulin for effective HbA1C control:1-4
- Equivalent to innovator in terms of:1-4
- Safety: Reduced risk of nocturnal hypoglycemia1-4
- Efficacy: Long lasting effect for 24 hours blood glucose control1-4
- Approved in Japan and more than 20 other countries4
- Does not contain ingredient derived from animal origin4
1. Verma M., Hazra P., Iyer H., et al., Basalog® is similar to Lantus® in producing glycemic control in patients with type 1 diabetes mellitus on multiple daily insulin regimens. Int J Diabetes Dev Ctries. 2011; 31(1):26–31.
2. Biocon S. A., Phase 3 Study of FFP-112 in Patients with Type I Diabetes Under Intensive Insulin Therapy, 2014.
3. Basalog® Package Insert. 4. Data on file, Biocon Limited.
Further information is available in section 11b, New In This Issue and mims.com.
Full prescribing information is available upon request.